Research 2020
Composites AM Market Opportunities

This 170-page study from 3dpbm Research provides an in-depth analysis of each major sub-segment in composites...

Loading Events

« All Events

Paradigm Shift in Cell Line Development

January 28 @ 09:00 - 10:00

The ultimate upgrade to cell line development workflows. Improved rate of monoclonality, faster speed, lower costs. Register for our webinar to learn more. Select the session that fits best when registering.

We believe that automation and microtechnology will bring the understanding and control of individual cells to a whole new level and empower our customers to serve patients faster and better.

Cell line development
Our technology offers documented proof of clonality with excellent cell viability and zero risk of cross-contamination; and it is suitable for many applications, including generating biopharmaceuticals like monoclonal antibodies.
Anaerobic cell isolation
Discover how our products enables automated and label-free single-cell isolation and studying from complex microbial samples.

Details

Date:
January 28
Time:
09:00 - 10:00
Event Category:
Website:
https://www.cellink.com/global/new-sight-teaser/

Organizer

CELLINK
Website:
www.cellink.com

Leave a Reply

Your email address will not be published.

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!